Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 1
2006 9
2007 8
2008 8
2009 6
2010 6
2011 11
2012 9
2013 11
2014 12
2015 9
2016 4
2017 6
2018 5
2019 3
2020 3
2021 2
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 17035274

101 results

Results by year

Filters applied: . Clear all
Page 1
Adalimumab in the therapy of uveitis in childhood.
Biester S, Deuter C, Michels H, Haefner R, Kuemmerle-Deschner J, Doycheva D, Zierhut M. Biester S, et al. Br J Ophthalmol. 2007 Mar;91(3):319-24. doi: 10.1136/bjo.2006.103721. Epub 2006 Oct 11. Br J Ophthalmol. 2007. PMID: 17035274 Free PMC article.
ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis.
Quartier P, Baptiste A, Despert V, Allain-Launay E, Koné-Paut I, Belot A, Kodjikian L, Monnet D, Weber M, Elie C, Bodaghi B; ADJUVITE Study Group. Quartier P, et al. Ann Rheum Dis. 2018 Jul;77(7):1003-1011. doi: 10.1136/annrheumdis-2017-212089. Epub 2017 Dec 23. Ann Rheum Dis. 2018. PMID: 29275333 Clinical Trial.
Response of pediatric uveitis to tumor necrosis factor-α inhibitors.
Lerman MA, Burnham JM, Chang PY, Daniel E, Foster CS, Hennessy S, Jabs DA, Joffe MM, Kaçmaz RO, Levy-Clarke GA, Mills MD, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Kempen JH. Lerman MA, et al. J Rheumatol. 2013 Aug;40(8):1394-403. doi: 10.3899/jrheum.121180. Epub 2013 Jul 1. J Rheumatol. 2013. PMID: 23818712 Free PMC article.
Adalimumab for juvenile idiopathic arthritis-associated uveitis.
Magli A, Forte R, Navarro P, Russo G, Orlando F, Latanza L, Alessio M. Magli A, et al. Graefes Arch Clin Exp Ophthalmol. 2013 Jun;251(6):1601-6. doi: 10.1007/s00417-013-2275-x. Epub 2013 Mar 1. Graefes Arch Clin Exp Ophthalmol. 2013. PMID: 23446556
Adalimumab therapy for refractory childhood uveitis.
Bravo-Ljubetic L, Peralta-Calvo J, Noval S, Pastora-Salvador N, Abelairas-Gómez J, Merino R. Bravo-Ljubetic L, et al. J AAPOS. 2013 Oct;17(5):456-9. doi: 10.1016/j.jaapos.2013.06.009. J AAPOS. 2013. PMID: 24160962
Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.
Ramanan AV, Dick AD, Jones AP, Hughes DA, McKay A, Rosala-Hallas A, Williamson PR, Hardwick B, Hickey H, Rainford N, Hickey G, Kolamunnage-Dona R, Culeddu G, Plumpton C, Wood E, Compeyrot-Lacassagne S, Woo P, Edelsten C, Beresford MW. Ramanan AV, et al. Health Technol Assess. 2019 Apr;23(15):1-140. doi: 10.3310/hta23150. Health Technol Assess. 2019. PMID: 31033434 Free PMC article. Clinical Trial.
Anti-TNF therapy for juvenile idiopathic arthritis-related uveitis.
Semeraro F, Arcidiacono B, Nascimbeni G, Angi M, Parolini B, Costagliola C. Semeraro F, et al. Drug Des Devel Ther. 2014 Mar 24;8:341-8. doi: 10.2147/DDDT.S54207. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 24711694 Free PMC article. Review.
101 results